Your browser doesn't support javascript.
loading
Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability.
Ellero-Simatos, S; Lewis, J P; Georgiades, A; Yerges-Armstrong, L M; Beitelshees, A L; Horenstein, R B; Dane, A; Harms, A C; Ramaker, R; Vreeken, R J; Perry, C G; Zhu, H; Sànchez, C L; Kuhn, C; Ortel, T L; Shuldiner, A R; Hankemeier, T; Kaddurah-Daouk, R.
Afiliação
  • Ellero-Simatos S; 1] Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, The Netherlands [2] Netherlands Metabolomics Centre, Leiden, The Netherlands.
  • Lewis JP; Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Georgiades A; Duke University Medical Center, Durham, North Carolina, USA.
  • Yerges-Armstrong LM; Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Beitelshees AL; Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Horenstein RB; Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Dane A; 1] Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, The Netherlands [2] Netherlands Metabolomics Centre, Leiden, The Netherlands.
  • Harms AC; 1] Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, The Netherlands [2] Netherlands Metabolomics Centre, Leiden, The Netherlands.
  • Ramaker R; 1] Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, The Netherlands [2] Netherlands Metabolomics Centre, Leiden, The Netherlands.
  • Vreeken RJ; 1] Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, The Netherlands [2] Netherlands Metabolomics Centre, Leiden, The Netherlands.
  • Perry CG; Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Zhu H; Duke University Medical Center, Durham, North Carolina, USA.
  • Sànchez CL; 1] Duke University Medical Center, Durham, North Carolina, USA [2] Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, RWTH Aachen University, Aachen, Germany.
  • Kuhn C; Duke University Medical Center, Durham, North Carolina, USA.
  • Ortel TL; Duke University Medical Center, Durham, North Carolina, USA.
  • Shuldiner AR; Program in Personalized and Genomic Medicine, Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hankemeier T; 1] Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, The Netherlands [2] Netherlands Metabolomics Centre, Leiden, The Netherlands.
  • Kaddurah-Daouk R; 1] Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina, USA [2] Duke Institute for Brain Sciences, Duke University, Durham, North Carolina, USA [3] Institute of Genome Science and Policy, Duke University, Durham, North Carolina, USA.
CPT Pharmacometrics Syst Pharmacol ; 3: e125, 2014 Jul 16.
Article em En | MEDLINE | ID: mdl-25029353

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Holanda